“I pity the TB patient”: a mixed methods study assessing the impact of the COVID-19 pandemic on TB services in two major Indonesian cities and distilling lessons for the future

Author:

Mashuri Yusuf AriORCID,Boettiger DavidORCID,Wahyuningtias Siska DianORCID,Negara Srila Nirmithya SalitaORCID,Subronto Yanri WijayantiORCID,Liverani MarcoORCID,Wulandari Luh Putu LilaORCID,Ahmad Riris AndonoORCID,Thabrany HasbullahORCID,Fardousi NasserORCID,Kaldor JohnORCID,Probandari AriORCID,Wiseman VirginiaORCID

Abstract

IntroductionIn Indonesia, a country with around 280 million people and the second-highest tuberculosis (TB) incidence rate in the world, the impact of the COVID-19 pandemic on TB care needs careful assessment so that future response strategies can be strengthened. We conducted a study comparing TB testing and treatment rates before and during the first 2 years of the COVID-19 pandemic in Indonesia, and the reasons for any disruptions to care.MethodsWe conducted retrospective secondary data analysis and qualitative interviews in Yogyakarta and Bandung, Indonesia. Routine data on TB testing and treatment were sourced from the national TB information system operated by the Indonesian Ministry of Health. TB testing and treatment outcomes were compared between two time periods: pre-COVID (2018–19); and during COVID-19 (2020–21). In-depth interviews were conducted with patients and health workers to explore their experiences in accessing and providing TB services during the pandemic.ResultsThere was a 45% (21 937/39 962) reduction in the number of patients tested for TB during the pandemic compared with pre-COVID-19, while the proportion of TB tests returning a positive result increased from 12% (4733/39 962) to 50% (10 945/21 937). The proportion of TB patients completing treatment increased by 2.6% during the pandemic, yet the proportion cured and the number of patients successfully treated both decreased (by 7% and 4.4%, respectively). Our qualitative interviews highlighted several factors influencing TB service access and delivery, including fear of being diagnosed with COVID-19 during TB-related clinic visits, fear of COVID-19 exposure among patients and health workers, healthcare facilities prioritising COVID-19 over other services, and mandatory mobility restrictions affecting both patients and health workers.ConclusionThe COVID-19 pandemic impacted TB testing and treatment outcomes in Bandung and Yogyakarta. Policymakers should consider these findings in designing strategies to ensure TB services are maintained and supported during future health crises.

Funder

Medical Research Council

Publisher

BMJ

Reference47 articles.

1. The World Bank . Incidence of tuberculosis (per 100,000 people) - Indonesia. Available: https://data.worldbank.org/indicator/SH.TBS.INCD?locations=ID [Accessed 13 Dec 2023].

2. Institute for Health Metrics and Evaluation . What causes the most deaths in Indonesia? Available: https://www.healthdata.org/research-analysis/health-by-location/profiles/indonesia [Accessed 13 Dec 2023].

3. World Health Organization . Global tuberculosis report 2020. Geneva World Health Organization; 2020.

4. World Health Organization . Global tuberculosis report 2021. Geneva World Health Organization; 2021.

5. World Health Organization . WHO Coronavirus disease (COVID-19) dashboard with vaccination data. Indonesia World Health Organization. Available: https://covid19.who.int/region/searo/country/id [accessed 02 Oct 2023]

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3